Sep 11 |
Veru to Present at the 2024 Cantor Global Healthcare Conference
|
Aug 11 |
Earnings Beat: Veru Inc. (NASDAQ:VERU) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
|
Aug 10 |
Veru Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Aug 10 |
Veru Inc. (VERU) Q3 2024 Earnings Call Transcript
|
Aug 8 |
Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates
|
Aug 8 |
Veru GAAP EPS of -$0.07, revenue of $4M
|
Aug 8 |
Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results
|
Aug 1 |
Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024
|
Jul 29 |
Veru to Participate in the BTIG Virtual Biotechnology Conference
|
Jul 2 |
Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism
|